CIBC World Market
RVMD icon

CIBC World Market’s Revolution Medicines RVMD Stock Holding History

CIBC World Market’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Buy
+14,093
New +$2.06M ﹤0.01% 777
2023
Q4 		– Sell
-20,805
Closed -$576K – 1301
2023
Q3 		$576K Buy
+20,805
New +$617K ﹤0.01% 862

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

CIBC World Market's RVMD Position: Q2 2026 in Review

CIBC World Market opened a new position in Revolution Medicines (RVMD) in Q2 2026: 14,093 shares worth $2.64M. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: CIBC World Market previously reported a position in RVMD as recently as Q3 2023.

CIBC World Market first reported a position in RVMD in Q3 2023 and has held it in 2 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • CIBC World Market held 14,093 shares of Revolution Medicines worth $2.64M as of Q2 2026.
  • Revolution Medicines was a new CIBC World Market position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #777 holding.
  • CIBC World Market first reported a position in Revolution Medicines in Q3 2023 and has held it in 2 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.